Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Karyopharm Therapeutics Inc. (KPTI)

Pharmaceutical Preparations

https://www.karyopharm.com

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.

85 WELLS AVENUE, SECOND FLOOR
NEWTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/06/2013

Market Cap

100,607,520

Shares Outstanding

114,530,000

Weighted SO

114,533,991

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

XFOR --.--%

HOOK --.--%

MREO --.--%

GRTX --.--%

ABOS --.--%

CTMX --.--%

NUVB --.--%

NLTX --.--%

ASMB --.--%

Beta

0.2080

Last Div

0.0000

Range

0.617-1.95

Chg

-0.0272

Avg Vol

1270408

Mkt Cap

100607520

Exch

NASDAQ

Country

US

Phone

617 658 0600

DCF Diff

1.5300

DCF

4.7100

Div Yield

0.0000

P/S

0.6907

EV Multiple

-1.6537

P/FV

-0.7390

Div Yield %

0.0000

P/E

-1.0861

PEG

-0.0268

Payout

0.0000

Current Ratio

3.6193

Quick Ratio

3.5590

Cash Ratio

1.4718

DSO

95.2040

DIO

210.5443

Op Cycle

305.7483

DPO

169.4167

CCC

136.3316

Gross Margin

0.9586

Op Margin

-0.8989

Pretax Margin

-0.6153

Net Margin

-0.6172

Eff Tax Rate

-0.0031

ROA

-0.4202

ROE

0.6689

ROCE

-0.8375

NI/EBT

1.0031

EBT/EBIT

0.6845

EBIT/Rev

-0.8989

Debt Ratio

0.9098

D/E

-1.4733

LT Debt/Cap

3.2400

Total Debt/Cap

3.1130

Int Coverage

-14.2087

CF/Debt

-0.6695

Equity Multi

-1.6193

Rec Turnover

3.8339

Pay Turnover

2.1545

Inv Turnover

1.7336

FA Turnover

38.3438

Asset Turnover

0.6808

OCF/Share

-1.0769

FCF/Share

-1.0785

Cash/Share

1.2572

OCF/Sales

-0.8948

FCF/OCF

1.0015

CF Coverage

-0.6695

ST Coverage

-36.7667

CapEx Coverage

-668.4000

Div&CapEx Cov

-668.4000

P/BV

-0.7390

P/B

-0.7390

P/S

0.6907

P/E

-1.0861

P/FCF

-0.7707

P/OCF

-0.7493

P/CF

-0.7493

PEG

-0.0268

P/S

0.6907

EV Multiple

-1.6537

P/FV

-0.7390

DPS

0.0000

Latest Headlines (EST)

MarketWatch Jan 06, 05:58 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks MarketWatch Jan 02, 12:26 The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks The Motley Fool Nov 02, 15:30 Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript

Revenue Product Segmentation